RAC1 and neoplasm: The recurrent mutation identified in seven of the tumor samples was a substitution of a proline for a serine at amino acid 29 in RAC1 (Ras-related C3 botulinum toxin substrate 1; RAC1P29S), a small Rho GTPase family protein with roles in proliferation, migration, and cytoskeletal rearrangements.